Suppr超能文献

中药方剂化浊调脂颗粒通过调节组蛋白乳糖化和 miR-155-5p 生成改善血脂异常。

Herbal medicine formula Huazhuo Tiaozhi granule ameliorates dyslipidaemia via regulating histone lactylation and miR-155-5p biogenesis.

机构信息

School of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, 310053, China.

Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100032, China.

出版信息

Clin Epigenetics. 2023 Nov 2;15(1):175. doi: 10.1186/s13148-023-01573-y.

Abstract

BACKGROUND

Huazhuo Tiaozhi granule (HTG) is a herbal medicine formula widely used in clinical practice for hypolipidaemic effects. However, the molecular mechanisms underlying dyslipidaemia treatment have not been well elucidated.

RESULTS

A significant reduction in the levels of total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) was observed in the serum of patients with dyslipidaemia after HTG treatment, without disruption in the levels of aspartate transaminase (AST), alanine transaminase (ALT), urea nitrogen (BUN), and creatinine (Cr). The dyslipidaemia rat model was induced by a high-fat diet and treated with Xuezhikang (0.14 g/kg/d) or HTG (9.33 g crude herb/kg/day) by gavage for 8 weeks. Body weight and liver index were markedly decreased in dyslipidaemic rats after treatment with Xuezhikang or HTG. HTG administration markedly ameliorated hyperlipidaemia by decreasing the levels of TC and LDL-C in serum and hepatic lipid accumulation. In vitro, lipid accumulation in LO2 and HepG2 cells was alleviated by serum treatment with HTG. High lactylation was observed in 198 proteins, including lactylation of histone H2B (K6), H4 (K80). Deep sequencing of microRNAs showed that miR-155-5p was significantly downregulated.

CONCLUSIONS

This study demonstrates that HTG is an effective and safe formula for treating dyslipidaemia, which promotes lactylation in hepatocytes, and the retardation of miR-155-5p biogenesis.

摘要

背景

化浊调脂颗粒(HTG)是一种广泛应用于临床降脂作用的中草药配方。然而,其治疗血脂异常的分子机制尚未得到充分阐明。

结果

血脂异常患者经 HTG 治疗后血清总胆固醇(TC)和低密度脂蛋白胆固醇(LDL-C)水平显著降低,天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)、尿素氮(BUN)和肌酐(Cr)水平无变化。采用高脂饮食诱导血脂异常大鼠模型,灌胃给予血脂康(0.14 g/kg/d)或 HTG(9.33 g 生药/kg/d)8 周。血脂康或 HTG 治疗后,血脂异常大鼠体重和肝指数明显降低。HTG 可降低血清 TC 和 LDL-C 水平,减轻肝脂质蓄积,明显改善高脂血症。体外实验中,HTG 血清处理可减轻 LO2 和 HepG2 细胞的脂质蓄积。198 种蛋白质发生高度酰化,包括组蛋白 H2B(K6)、H4(K80)的酰化。miRNA 深度测序显示 miR-155-5p 显著下调。

结论

本研究表明,HTG 是一种治疗血脂异常的有效且安全的配方,可促进肝细胞的酰化作用,以及 miR-155-5p 生物发生的阻滞。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验